EP1091808B1 - Device for determining an analyte in a liquid sample - Google Patents

Device for determining an analyte in a liquid sample Download PDF

Info

Publication number
EP1091808B1
EP1091808B1 EP99925064A EP99925064A EP1091808B1 EP 1091808 B1 EP1091808 B1 EP 1091808B1 EP 99925064 A EP99925064 A EP 99925064A EP 99925064 A EP99925064 A EP 99925064A EP 1091808 B1 EP1091808 B1 EP 1091808B1
Authority
EP
European Patent Office
Prior art keywords
zone
capillary
diffusion means
support
capillary diffusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP99925064A
Other languages
German (de)
French (fr)
Other versions
EP1091808A1 (en
Inventor
Milovan Stankov
Raphael Donati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VEDA LAB
Original Assignee
VEDA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9528186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1091808(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by VEDA LAB filed Critical VEDA LAB
Publication of EP1091808A1 publication Critical patent/EP1091808A1/en
Application granted granted Critical
Publication of EP1091808B1 publication Critical patent/EP1091808B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0825Test strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0633Valves, specific forms thereof with moving parts
    • B01L2400/065Valves, specific forms thereof with moving parts sliding valves
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/806Fertility tests

Definitions

  • the present invention relates to a device for determination of an analyte present in a sample liquid.
  • Analyte means any entity, chemical, biochemical, or biological, that we want to determine, that is to say, identify or detect, and / or quantify, and / or measure.
  • the present invention will be introduced, defined, and described by reference to the determination of a biological entity, especially a hormone, for example the hormone hcG to detect the pregnancy status of a woman.
  • Liquid sample means any sample in which the analyte sought is in solution or suspension, as directly applied or treated by the device of determination of which it will be question below.
  • This liquid sample can itself have been obtained from a sample or other sample containing the analyte, for example a fluid body, by physical treatment, and / or chemical, and / or organic. This means in particular that the middle of Dissolution or dispersion belonging to the sample liquid is not necessarily aqueous.
  • the user removes the cap, then puts the liquid sample, for example a stream of urine, in direct contact with the collection area of the second means of capillary diffusion.
  • the liquid sample migrates first, in the reference direction, to the zone upstream of the first capillary diffusion means, in which, on the one hand, causes the first reagent, and on the other hand the analyte binds to the latter, to form a conjugate.
  • the aforementioned conjugate arrives via capillary drive in the downstream zone, in which the second reagent captures, and therefore immobilizes and concentrate, directly or indirectly, the first reagent, and hence the conjugate.
  • the existence and / or the captured quantity of the conjugate can be read, and / or measured, directly or indirectly, for example to the naked eye in the case of a particulate marker, or by any means of detection and / or appropriate measure.
  • the two devices previously described have in on the one hand, the provision of the two means of capillary diffusion, on one and the same element, know the grip support in the first case, and the movable organ in the second case, and on the other hand a structural continuity of capillary flow, this is at say permanent, the liquid sample of the second means of capillary diffusion to the first means of capillary diffusion.
  • the present invention relates to a device for removing any additional means of removable protection of the collection area of the liquid sample, while isolating the latter from the outside of the device, as the latter is not used, ie used or armed for taking a liquid sample, and then reading the result concerning the analyte.
  • a device Compared to WO 97/26083, a device according to the present invention is distinguished in that the transfer zone of the second capillary diffusion means is removably arranged with respect to an upstream zone of the first capillary diffusion means, so that, in the projecting position of the capturing member, said transfer zone is not in continuity of capillary flow with said upstream zone, and in the retracted position of said capturing member, said transfer zone and said zone upstream are in continuity of capillary flow, while a set of reagents predetermined for the detection and / or quantification of the analyte comprises at least, on the one hand a first reagent comprising a marker, visible and / or measurable, deposited in the free state, or on the first capillary diffusion means, upstream of said downstream zone, or on the second capillary diffusion means, and secondly a second reagent fixed in the zone e downstream of the first capillary diffusion means, for the direct or indirect capture of the first reagent.
  • the device according to the invention is distinguished by the dissociation of the two means of capillary diffusion, and by the possibility of isolating temporarily these two means with respect to the flow capillary of the liquid sample.
  • the device according to the invention is distinguished, besides the set of predetermined reagents chosen for the detection and / or quantification of the analyte, by the fact that the first means of capillary diffusion remains side of the gripping support, and as a result the capture organ is essentially assigned to the sampling of the liquid sample.
  • the invention brings the following advantages.
  • the displacement of the second diffusion means capillary, away from and away from the first means of capillary diffusion, allows for a length or a given size of the device, to have a more large collection length of the liquid sample, in the projecting or protruding position of said device.
  • a device according to the invention can be used with any set of predetermined reagents, depending of the desired analyte in the liquid sample, of a and the operating protocol adopted for the determination on the other hand.
  • Reagent means any entity, chemical, biochemical, or biological likely to bind with the analyte and / or another reagent.
  • binding is meant any link strong, for example covalent, or weak, for example type antigen / antibody or avidin / streptavidin.
  • the reagents considered according to the invention are entities ligand or anti-ligand type, and this by relative to the analyte or other reagent, of type organic.
  • the reagents such as antibodies, antigens, haptens, avidin / streptavidin, but also peptides, proteins, and polynucleotides.
  • the first and second reagents are respectively two monoclonal antibodies specific, identical or different, directed against the analyte.
  • Marker means any physical entity, chemical, biochemical, or biological, allowing directly or indirectly the determination of the first reagent, particularly when bound, directly or indirectly indirectly, to the analyte.
  • a marker known per se, can be for example an enzyme, or particles metal, for example gold particles, obtained by example from colloidal gold.
  • the first reagent is deposited on the second means of capillary diffusion, in particular downstream of the organ collection area of capture, or the first reagent is deposited on the first means of capillary diffusion, in particular downstream of the upstream zone of the said first means, but upstream of the downstream zone accessible to an observation external.
  • an analyte constituted by a biological entity comprising two ligands, likely to link with the first reagent and a third reagent the latter is deposited at the free state, on a porous support, in this case the second means of capillary diffusion or the first means capillary scattering at a functionally upstream of the downstream zone of the first diffusion means.
  • the second reagent is predetermined for capturing the third reagent.
  • another predetermined reagent for binding directly or indirectly with the first reagent is fixed in a adjacent area but downstream of the downstream zone of the first means of diffusion, this adjacent zone being also accessible to an external observation.
  • the first reagent comprises a particulate marker, for example gold particles, visible and / or directly measurable, when concentrated in the downstream zone of the first diffusion means.
  • a particulate marker for example gold particles, visible and / or directly measurable
  • the support of 1 comprises a longitudinal slide 5, of which the shape is adapted to the movement path of said member 4, and the latter comprises a control member 6 manual crossing this slide.
  • the race of the organ 6 in the slide 5 determines the two extreme positions of the capture member 4, and as shown in FIG. has a length greater than the recovery length of the transfer zone 41b of the second diffusion means 41 capillary, and the upstream zone (2b) of the first means of capillary diffusion, in the retracted position of device.
  • the first means 2 of capillary diffusion is obtained by assembling different sections or pieces, themselves fixed on a band 28 made of plastic transparent, and in permanent continuity of flow capillary when assembled to each other.
  • the capture member 4 comprises a carriage 42 of supporting the second means 41 of capillary diffusion, included in the housing 1 or gripping support.
  • This last and the carriage 42 comprise guide means moving said carriage, more particularly visible in Figure 6, consisting of two slides 45 and 46 belonging to the housing 1, the superior and the other bottom, and aligned, and in two ribs 43 and 44 corresponding to the carriage 42, sliding in the slides 45 and 46 respectively.
  • the second diffusion means 41 is in the form of a relatively rigid rod, and the carriage 42 comprises a rear stop 42a with respect to the direction of travel said carriage, and a member 42b for holding the rod 41, having the shape of a ring.
  • the housing 1 also includes a means 47 for actuating the carriage 42, with manual control 48. More specifically, the actuating means 47 comprises a band 49 semi-rigid, shaped hairpin, one of which branch 49a has on its outer face a member 48 the other limb has one end linked to the carriage 42.
  • the housing 1 comprises a path 50 for guiding and pulling the strip, also shaped hairpin, and secondly a 1f window adapted to the passage of the organ of 48, the length of which is adapted to the race of displacement of the capture organ 4. as shown the comparison between figures 4 and 5, this race a much longer length than the recovery length of the transfer zone 41b of the second means of capillary diffusion 41, and the upstream zone 2b of the first capillary diffusion means 2, in the position retracted device.
  • the band 49 circulates in the guide path 50 and pushes the carriage 42 towards the protruding position of the capture member 2. In sense reverse, the carriage 42 is moved to the position retracted from the capture member 4.
  • the first means 2 of capillary diffusion is tight and kept inside the housing between ribs on arranged parallel to the flow direction 60 capillary.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The invention concerns a device for determining an analyte in a liquid sample, comprising: a) a gripping support (1); b) first capillary diffusing means (2) integral with the gripping support (1) comprising a downstream zone (2a) accessible to external observation; c) a set of predetermined reagents for detecting and/or quantifying the analyte; d) a member for collecting (4) the liquid sample mounted on the support (1). The invention is characterized in that the member for collecting (4) the liquid sample is mounted mobile or fixed on the support; second capillary diffusion means (41) extends from a zone collecting (41a) said sample, to a zone transferring (41b) the latter; and an upstream zone (2b) of said first capillary diffusion means (2) is arranged to be urged temporarily to constitute continuous capillary flow with the second diffusion means (41) transferring zone (41b), when the collecting member (4) is in the retracted position.

Description

La présente invention concerne un dispositif de détermination d'un analyte présent dans un échantillon liquide.The present invention relates to a device for determination of an analyte present in a sample liquid.

Par "analyte", on entend toute entité, chimique, biochimique, ou biologique, que l'on veut déterminer, c'est-à-dire identifier ou détecter, et/ou quantifier, et/ou mesurer."Analyte" means any entity, chemical, biochemical, or biological, that we want to determine, that is to say, identify or detect, and / or quantify, and / or measure.

A titre préférentiel, et de manière non exclusive, la présente invention sera introduite, définie, et décrite par référence à la détermination d'une entité biologique, notamment une hormone, par exemple l'hormone hcG permettant de détecter l'état de grossesse d'une femme.As a preferential, and non-exclusive, the present invention will be introduced, defined, and described by reference to the determination of a biological entity, especially a hormone, for example the hormone hcG to detect the pregnancy status of a woman.

Par "échantillon liquide", on entend tout échantillon dans lequel l'analyte recherché est en solution ou suspension, tel qu'il est directement appliqué ou traité par le dispositif de détermination dont il sera question ci-après. Cet échantillon liquide peut lui-même avoir été obtenu à partir d'un prélèvement ou autre échantillon contenant l'analyte, par exemple un fluide corporel, par traitement physique, et/ou chimique, et/ou biologique. Ceci signifie en particulier que le milieu de dissolution ou dispersion appartenant à l'échantillon liquide n'est pas nécessairement aqueux."Liquid sample" means any sample in which the analyte sought is in solution or suspension, as directly applied or treated by the device of determination of which it will be question below. This liquid sample can itself have been obtained from a sample or other sample containing the analyte, for example a fluid body, by physical treatment, and / or chemical, and / or organic. This means in particular that the middle of Dissolution or dispersion belonging to the sample liquid is not necessarily aqueous.

Conformément aux Figures 8 et 9 du document EP-A-0291 194, on a décrit un dispositif de détermination d'un analyte, en particulier pour la détermination de l'hormone hcG, répondant à la définition générale suivante.According to Figures 8 and 9 of EP-A-0291 194, there has been described a device for determining a analyte, especially for the determination of the hormone hcG, as defined below.

Un tel dispositif comprend :

  • a) un support de préhension, ayant la forme d'un boítier, comprenant à une extrémité une ouverture pour le passage du deuxième moyen de diffusion capillaire dont il sera question ci-après, saillant à l'extérieur du boítier, et ayant une zone de collection d'un échantillon liquide ; ce boítier comporte, à l'opposé de l'organe de captation, une fenêtre registrée avec au moins la zone aval du premier moyen de diffusion capillaire dont il sera question ci-après ;
  • b) ledit premier moyen de diffusion capillaire, dans une direction et un sens de référence, solidaire et fixé dans le support de préhension, comprenant une zone aval accessible à une observation externe, grâce à la fenêtre précitée registrée avec ladite zone aval ;
  • c) un ensemble de réactifs prédéterminés pour la détection et/ou quantification de l'analyte, comprenant :
    • un premier réactif comprenant un marqueur, visible et/ou mesurable, ce premier réactif étant disposé à l'état libre, dans une zone amont du premier moyen de diffusion capillaire ;
    • et un second réactif fixé, c'est-à-dire immobilisé, dans la zone aval du premier moyen de diffusion capillaire, pour la capture directe ou indirecte du premier réactif ;
  • d) ledit deuxième moyen de diffusion capillaire, ayant la forme d'un batonnet rigide, monté et solidaire du support de préhension, de manière à établir en permanence dans le boítier une continuité d'écoulement capillaire, à partir de la zone de collection du deuxième moyen de diffusion capillaire, vers la zone amont du premier moyen de diffusion capillaire, puis de cette dernière vers la zone aval du premier moyen de diffusion capillaire,
  • e) et un capuchon amovible, de protection de la partie saillante du deuxième moyen de diffusion capillaire, et plus précisément de sa zone de collection.
  • Such a device comprises:
  • a) a gripping support, having the form of a housing, comprising at one end an opening for the passage of the second capillary diffusion means which will be discussed below, projecting outside the housing, and having a zone collection of a liquid sample; this housing comprises, opposite the capturing member, a window registered with at least the downstream zone of the first capillary diffusion means which will be discussed below;
  • b) said first capillary diffusion means, in a direction and a reference direction, integral and fixed in the gripping support, comprising a downstream zone accessible to an external observation, by means of the aforementioned window registered with said downstream zone;
  • c) a set of predetermined reagents for the detection and / or quantification of the analyte, comprising:
    • a first reagent comprising a marker, visible and / or measurable, said first reagent being disposed in the free state, in an upstream zone of the first capillary diffusion means;
    • and a second reagent attached, i.e. immobilized, in the downstream zone of the first capillary diffusion means, for the direct or indirect capture of the first reagent;
  • d) said second capillary diffusion means, in the form of a rigid batten, mounted and integral with the gripping support, so as to establish permanently in the housing capillary flow continuity, from the collection area of the second capillary diffusion means, towards the upstream zone of the first capillary diffusion means, and then of the latter towards the downstream zone of the first capillary diffusion means,
  • e) and a removable cap, for protecting the projecting portion of the second capillary diffusion means, and more precisely of its collection zone.
  • Le fonctionnement du dispositif précédemment décrit se déduit de la description précédente.The operation of the device previously described is deduced from the previous description.

    L'utilisateur retire le capuchon, puis met l'échantillon liquide, par exemple un flot d'urine, en contact direct avec la zone de collection du deuxième moyen de diffusion capillaire. L'échantillon liquide migre d'abord, dans la direction de référence, vers la zone amont du premier moyen de diffusion capillaire, dans laquelle, d'une part il entraíne le premier réactif, et d'autre part l'analyte se lie à ce dernier, pour former un conjugué. Puis, toujours par migration capillaire de l'échantillon liquide, le conjugué précité parvient par entraínement capillaire dans la zone aval, dans laquelle le second réactif capture, et donc immobilise et concentre, directement ou indirectement, le premier réactif, et partant le conjugué. Par la fenêtre du boítier, l'existence et/ou la quantité capturée du conjugué peut être lue, et/ou mesurée, directement ou indirectement, par exemple à l'oeil nu dans le cas d'un marqueur particulaire, ou par tous moyens de détection et/ou mesure appropriés.The user removes the cap, then puts the liquid sample, for example a stream of urine, in direct contact with the collection area of the second means of capillary diffusion. The liquid sample migrates first, in the reference direction, to the zone upstream of the first capillary diffusion means, in which, on the one hand, causes the first reagent, and on the other hand the analyte binds to the latter, to form a conjugate. Then, still by capillary migration of the liquid sample, the aforementioned conjugate arrives via capillary drive in the downstream zone, in which the second reagent captures, and therefore immobilizes and concentrate, directly or indirectly, the first reagent, and hence the conjugate. Through the window of housing, the existence and / or the captured quantity of the conjugate can be read, and / or measured, directly or indirectly, for example to the naked eye in the case of a particulate marker, or by any means of detection and / or appropriate measure.

    Sans que l'ensemble de réactifs mis en oeuvre ou les réactifs soient précisés, par référence à ses figures 1 à 6, le document WO-A-97 26 083 décrit un dispositif de détermination d'un analyte dans un échantillon liquide, comprenant :

  • a) un support de préhension, ayant la forme d'un étui allongé et plat, ouvert à ses deux extrémités, comportant sur une face et à une première extrémité une fenêtre ; ce boítier sert de coulisse à l'organe de captation de l'échantillon liquide dont il sera question ci-après.
  • b) un organe mobile à la manière d'un coulisseau, monté de manière déplaçable par rapport au support de préhension ; cet organe mobile consiste en un boítier allongé, obtenu par assemblage définitif de deux parties ou coques complémentaires, et incorpore, en continuité d'écoulement capillaire, d'une part un premier moyen de diffusion capillaire, entièrement compris dans le boítier, comprenant une zone aval accessible à une observation externe, et d'autre part un deuxième moyen de diffusion capillaire, compris pour partie dans le boítier, et comprenant une zone extrême de collection de l'échantillon liquide, saillant à l'extérieur du boítier ; le boítier comporte par ailleurs, à l'opposé d'une partie permettant sa manipulation, une fenêtre registrée avec la zone aval du premier moyen de diffusion capillaire ; l'organe mobile est déplaçable par rapport au support de préhension, à partir d'une position de départ dans laquelle la zone de collection de l'échantillon liquide de l'organe mobile est susceptible d'être mise au contact de ce dernier, et dans laquelle la fenêtre du boítier est masquée par le support de préhension, en dehors du support de préhension, à une position rétractée, dans laquelle, la zone de collection précitée est comprise et incorporée entièrement dans le support de préhension, et dans laquelle la fenêtre du boítier est registrée avec celle du support de préhension, ce qui rend la zone aval du premier moyen de diffusion capillaire, accessible à une observation.
  • Without the set of reagents used or the reagents being specified, with reference to FIGS. 1 to 6, the document WO-A-97 26 083 describes a device for determining an analyte in a liquid sample, comprising:
  • a) a gripping support, in the form of an elongated and flat case, open at both ends, having on one face and at one end a window; this housing serves as a slide to the liquid sample collection member which will be discussed below.
  • b) a movable member in the manner of a slider, movably mounted relative to the gripping support; this movable member consists of an elongated housing, obtained by definitively assembling two complementary parts or shells, and incorporates, in continuity of capillary flow, firstly a first capillary diffusion means, entirely comprised in the housing, comprising a zone downstream accessible to an external observation, and secondly a second capillary diffusion means, partly comprised in the housing, and comprising an end zone for collecting the liquid sample, projecting outside the housing; the housing further comprises, opposite to a part allowing its manipulation, a window registered with the downstream zone of the first capillary diffusion means; the movable member is movable relative to the gripping support, from a starting position in which the collection zone of the liquid sample of the movable member is likely to be brought into contact with the latter, and in which the window of the housing is masked by the gripping support, outside the gripping support, to a retracted position, in which, the aforesaid collection zone is included and incorporated entirely in the gripping support, and in which the window housing is registered with that of the gripping support, which makes the downstream zone of the first capillary diffusion means, accessible to an observation.
  • Le fonctionnement du dispositif précédemment décrit se déduit de sa structure :

    • après collection de l'échantillon liquide, l'organe mobile est amené dans la position rétractée,
    • le résultat de la réaction sur le premier moyen de diffusion capillaire, est observable au travers des deux fenêtres registrées de l'organe mobile et du support de préhension respectivement.
    The operation of the device described above is deduced from its structure:
    • after collection of the liquid sample, the movable member is brought into the retracted position,
    • the result of the reaction on the first capillary diffusion means is observable through the two registered windows of the movable member and the gripping support respectively.

    Les deux dispositifs précédemment décrits, ont en commun, d'une part la disposition des deux moyens de diffusion capillaire, sur un seul et même élément, à savoir le support de préhension dans le premier cas, et l'organe mobile dans le second cas, et d'autre part une continuité structurelle d'écoulement capillaire, c'est à dire permanente, de l'échantillon liquide du deuxième moyen de diffusion capillaire vers le premier moyen de diffusion capillaire.The two devices previously described, have in on the one hand, the provision of the two means of capillary diffusion, on one and the same element, know the grip support in the first case, and the movable organ in the second case, and on the other hand a structural continuity of capillary flow, this is at say permanent, the liquid sample of the second means of capillary diffusion to the first means of capillary diffusion.

    La présente invention a pour objet un dispositif permettant de supprimer tout moyen supplémentaire de protection amovible de la zone de collection de l'échantillon liquide, tout en isolant cette dernière par rapport à l'extérieur du dispositif, tant que ce dernier n'est pas utilisé, c'est à dire mis en oeuvre ou armé pour le prélèvement d'un échantillon liquide, puis la lecture du résultat concernant l'analyte.
    Par rapport au document WO 97/26083, un dispositif selon la présente invention se distingue en ce que la zone de transfert du deuxième moyen de diffusion capillaire est agencée de manière amovible, par rapport à une zone amont du premier moyen de diffusion capillaire, en sorte que, dans la position saillante de l'organe de captation, ladite zone de transfert n'est pas en continuité d'écoulement capillaire avec ladite zone amont, et dans la position rétractée dudit organe de captation, ladite zone de transfert et ladite zone amont sont en continuité d'écoulement capillaire, tandis qu'un ensemble de réactifs prédéterminé pour la détection et/ou quantification de l'analyte comprend au moins, d'une part un premier réactif comprenant un marqueur, visible et/ou mesurable, déposé à l'état libre, ou sur le premier moyen de diffusion capillaire, en amont de ladite zone aval, ou sur le second moyen de diffusion capillaire, et d'autre part un second réactif fixé dans la zone aval du premier moyen de diffusion capillaire, pour la capture directe ou indirecte du premier réactif.
    The present invention relates to a device for removing any additional means of removable protection of the collection area of the liquid sample, while isolating the latter from the outside of the device, as the latter is not used, ie used or armed for taking a liquid sample, and then reading the result concerning the analyte.
    Compared to WO 97/26083, a device according to the present invention is distinguished in that the transfer zone of the second capillary diffusion means is removably arranged with respect to an upstream zone of the first capillary diffusion means, so that, in the projecting position of the capturing member, said transfer zone is not in continuity of capillary flow with said upstream zone, and in the retracted position of said capturing member, said transfer zone and said zone upstream are in continuity of capillary flow, while a set of reagents predetermined for the detection and / or quantification of the analyte comprises at least, on the one hand a first reagent comprising a marker, visible and / or measurable, deposited in the free state, or on the first capillary diffusion means, upstream of said downstream zone, or on the second capillary diffusion means, and secondly a second reagent fixed in the zone e downstream of the first capillary diffusion means, for the direct or indirect capture of the first reagent.

    Par conséquent, par rapport aux documents EP-A-0291 194 et WO-A-97 26083, le dispositif selon l'invention se distingue par la dissociation des deux moyens de diffusion capillaire, et par la possibilité d'isoler temporairement ces deux moyens vis à vis de l'écoulement capillaire de l'échantillon liquide.Therefore, compared to EP-A-0291 194 and WO-A-97 26083, the device according to the invention is distinguished by the dissociation of the two means of capillary diffusion, and by the possibility of isolating temporarily these two means with respect to the flow capillary of the liquid sample.

    Et de plus, par rapport au document WO-A-97 26083, le dispositif selon l'invention se distingue, outre l'ensemble de réactifs prédéterminés choisis pour la détection et/ou quantification de l'analyte, par le fait que le premier moyen de diffusion capillaire demeure du côté du support de préhension, et qu'en conséquence l'organe de captation est affecté pour l'essentiel au prélèvement de l'échantillon liquide.And moreover, compared to the document WO-A-97 26083, the device according to the invention is distinguished, besides the set of predetermined reagents chosen for the detection and / or quantification of the analyte, by the fact that the first means of capillary diffusion remains side of the gripping support, and as a result the capture organ is essentially assigned to the sampling of the liquid sample.

    L'invention apporte les avantages suivants.The invention brings the following advantages.

    La possibilité d'isoler, vis à vis de l'écoulement liquide les deux moyens de diffusion capillaire, permet de séparer et séquencer le prélèvement proprement dit, et la ou les réactions requises pour la détection et/ou quantification de l'analyte, à savoir d'effectuer ledit prélèvement avant la ou les réactions.The possibility of isolating, with respect to the flow liquid both capillary diffusion means, allows to separate and sequence the actual sample, and the or the reactions required for detection and / or quantification of the analyte, namely to perform said sampling before the reaction (s).

    Ceci est important pour éviter le démarrage de la ou des réactions requises avant d'avoir permis un prélèvement d'une quantité maximum ou optimum de l'échantillon liquide à analyser.This is important to avoid starting the or required reactions before allowing a collection of a maximum or optimum amount of the liquid sample to be analyzed.

    Le déplacement du deuxième moyen de diffusion capillaire, à l'écart et à distance du premier moyen de diffusion capillaire, permet pour une longueur ou un encombrement donné du dispositif, de disposer d'une plus grande longueur de collection de l'échantillon liquide, dans la position saillante ou en saillie dudit dispositif.The displacement of the second diffusion means capillary, away from and away from the first means of capillary diffusion, allows for a length or a given size of the device, to have a more large collection length of the liquid sample, in the projecting or protruding position of said device.

    Un dispositif selon l'invention peut être utilisé avec tout ensemble de réactifs prédéterminés, en fonction de l'analyte recherché dans l'échantillon liquide, d'une part, et du protocole opératoire retenu pour la détermination d'autre part.A device according to the invention can be used with any set of predetermined reagents, depending of the desired analyte in the liquid sample, of a and the operating protocol adopted for the determination on the other hand.

    Par réactif, on entend toute entité, chimique, biochimique, ou biologique susceptible de se lier avec l'analyte et/ou un autre réactif.Reagent means any entity, chemical, biochemical, or biological likely to bind with the analyte and / or another reagent.

    Par "lier", ou "liaison", on entend toute liaison forte, par exemple covalente, ou faible, par exemple du type antigène/anticorps ou avidine/streptavidine.By "bind", or "link", is meant any link strong, for example covalent, or weak, for example type antigen / antibody or avidin / streptavidin.

    Préférentiellement, mais de manière non exclusive, les réactifs considérés selon l'invention sont des entités biologiques, du type ligand ou anti-ligand, et ceci par rapport à l'analyte ou un autre réactif, de type biologique. Dans cette catégorie, sont rangés les réactifs tels que anticorps, antigènes, haptènes, avidine/streptavidine, mais aussi les peptides, protéines, et polynucléotides.Preferentially, but not exclusively, the reagents considered according to the invention are entities ligand or anti-ligand type, and this by relative to the analyte or other reagent, of type organic. In this category are stored the reagents such as antibodies, antigens, haptens, avidin / streptavidin, but also peptides, proteins, and polynucleotides.

    A titre d'exemple, les premier et second réactifs sont respectivement deux anticorps monoclonaux spécifiques, identiques ou différents, dirigés contre l'analyte. By way of example, the first and second reagents are respectively two monoclonal antibodies specific, identical or different, directed against the analyte.

    Par "marqueur", on entend toute entité physique, chimique, biochimique, ou biologique, permettant directement ou indirectement la détermination du premier réactif, en particulier lorsqu'il est lié, directement ou indirectement, à l'analyte. Un tel marqueur, connu en soi, peut être par exemple une enzyme, ou encore des particules métalliques, par exemple des particules d'or, obtenues par exemple à partir d'or colloïdal."Marker" means any physical entity, chemical, biochemical, or biological, allowing directly or indirectly the determination of the first reagent, particularly when bound, directly or indirectly indirectly, to the analyte. Such a marker, known per se, can be for example an enzyme, or particles metal, for example gold particles, obtained by example from colloidal gold.

    Selon l'invention, le premier réactif est déposé sur le second moyen de diffusion capillaire, en particulier en aval de la zone de collection de l'organe de captation, ou encore le premier réactif est déposé sur le premier moyen de diffusion capillaire, en particulier en aval de la zone amont dudit premier moyen, mais en amont de la zone aval accessible à une observation externe.According to the invention, the first reagent is deposited on the second means of capillary diffusion, in particular downstream of the organ collection area of capture, or the first reagent is deposited on the first means of capillary diffusion, in particular downstream of the upstream zone of the said first means, but upstream of the downstream zone accessible to an observation external.

    De manière connue en soi, l'ensemble des réactifs prédéterminés en fonction de l'analyte et du protocole de détermination, peut être mis en oeuvre selon différents formats :

    • selon un format sandwich, les premier et second réactifs sont alors prédéterminés pour se lier respectivement et spécifiquement avec l'analyte, par exemple sur deux sites épitopiques, identiques ou différents de l'analyte, lorsqu'il consiste en une molécule biologique ;
    • selon un format compétition, le premier réactif ou le second réactif est prédéterminé à l'identique ou de manière similaire à l'analyte, pour se lier avec l'autre réactif, en compétition avec l'analyte.
    In a manner known per se, the set of reagents predetermined according to the analyte and the determination protocol can be implemented according to various formats:
    • in a sandwich format, the first and second reagents are then predetermined to bind respectively and specifically with the analyte, for example on two epitopic sites, identical or different from the analyte, when it consists of a biological molecule;
    • in a competition format, the first reagent or the second reagent is predetermined identically or in a manner similar to the analyte, to bind with the other reagent, in competition with the analyte.

    Et encore, dans le cas d'un analyte constitué par une entité biologique comprenant deux ligands, susceptibles de se lier respectivement avec le premier réactif et un troisième réactif, ce dernier est déposé à l'état libre, sur un support poreux, en l'occurrence le second moyen de diffusion capillaire ou le premier moyen de diffusion capillaire, à un endroit fonctionnellement en amont de la zone aval du premier moyen de diffusion. Et le deuxième réactif est prédéterminé pour la capture du troisième réactif.And again, in the case of an analyte constituted by a biological entity comprising two ligands, likely to link with the first reagent and a third reagent, the latter is deposited at the free state, on a porous support, in this case the second means of capillary diffusion or the first means capillary scattering at a functionally upstream of the downstream zone of the first diffusion means. And the second reagent is predetermined for capturing the third reagent.

    Pour contrôler que la ou les réactions nécessaires à la détermination de l'analyte ont bien eu lieu, un autre réactif prédéterminé pour se lier directement ou indirectement avec le premier réactif, est fixé dans une zone adjacente mais en aval de la zone aval du premier moyen de diffusion, cette zone adjacente étant également accessible à une observation externe.To control that the necessary reaction (s) the determination of the analyte took place, another predetermined reagent for binding directly or indirectly with the first reagent, is fixed in a adjacent area but downstream of the downstream zone of the first means of diffusion, this adjacent zone being also accessible to an external observation.

    A titre d'exemple, le premier réactif comprend un marqueur particulaire, par exemple des particules d'or, visibles et/ou mesurables directement, lorsqu'il est concentré dans la zone aval du premier moyen de diffusion.By way of example, the first reagent comprises a particulate marker, for example gold particles, visible and / or directly measurable, when concentrated in the downstream zone of the first diffusion means.

    La présente invention est maintenant décrite par référence au dessin annexé, dans lequel :

    • la figure 1 représente en perspective, avec arrachement partiel, dans la position saillante de l'organe de captation, un dispositif selon un premier mode d'exécution de l'invention ;
    • la figure 2 représente le dispositif représenté à la figure 1, en coupe longitudinale et verticale, dans la position rétractée de l'organe de captation ;
    • la figure 3 représente une vue en perspective, dans la position saillante de l'organe de captation, un dispositif selon un deuxième mode d'exécution de l'invention ;
    • la figure 4 représente une vue éclatée en perspective du dispositif représenté à la figure 3, dans la position rétractée de l'organe de captation ;
    • la figure 5 représente une vue en coupe longitudinale et horizontale du dispositif représenté à la figure 4, dans la position rétractée de l'organe de captation ;
    • la figure 6 représente une vue en coupe transversale au niveau de l'organe 42b de maintien en position du bâtonnet 41, du dispositif représenté aux figures 4 et 5 ;
    • la figure 7 représente une vue éclatée du premier moyen de diffusion capillaire, identique pour les deux modes d'exécution de l'invention, et mis en oeuvre dans la même position, comme montré par les figures 1 et 2 en particulier.
    The present invention is now described with reference to the accompanying drawing, in which:
    • Figure 1 shows in perspective, partially broken away, in the projecting position of the capture member, a device according to a first embodiment of the invention;
    • FIG. 2 represents the device represented in FIG. 1, in longitudinal and vertical section, in the retracted position of the capturing member;
    • FIG. 3 represents a perspective view, in the projecting position of the capture member, of a device according to a second embodiment of the invention;
    • FIG. 4 represents an exploded perspective view of the device represented in FIG. 3, in the retracted position of the capturing member;
    • Figure 5 shows a longitudinal and horizontal sectional view of the device shown in Figure 4, in the retracted position of the capture member;
    • Figure 6 shows a cross-sectional view at the member 42b for holding the rod 41 in position, the device shown in Figures 4 and 5;
    • FIG. 7 represents an exploded view of the first capillary diffusion means, identical for the two embodiments of the invention, and implemented in the same position, as shown by FIGS. 1 and 2 in particular.

    Conformément aux figures 1 et 2, un dispositif selon l'invention comprend :

    • un support de préhension 1 ayant la forme d'un boítier, comprenant, à une extrémité distale une ouverture 1c pour le passage de l'organe de captation 4 décrit ci-après vers la position saillante, et à l'opposé de cette extrémité une fenêtre 1d registrée avec au moins une zone aval 2a du premier moyen 2 de diffusion capillaire, décrit ci-après ;
    • le premier des deux moyens de diffusion capillaire, ayant la forme d'une bandelette multi-couche, solidaire du support de préhension 1, et comprenant la zone aval 2a accessible à une observation externe ; ce premier moyen est plus particulièrement représenté en vue éclatée à la figure 2, et sera décrit ci-après en détail ;
    • un ensemble de réactifs prédéterminés pour la détection et/ou quantification de l'analyte, comprenant au moins :
      • un premier réactif 31, comprenant un marqueur visible et/ou mesurable, ce premier réactif étant disposé à l'état libre sur le premier moyen de diffusion 2, en particulier en aval de la zone amont 2b, dont il sera question ci-après ;
      • et un second réactif 32 fixé dans la zone aval 2a du premier moyen de diffusion 2, pour la capture directe ou indirecte du premier réactif ;
      • un autre réactif 33, prédéterminé pour se lier avec le premier réactif 31, fixé dans une zone 2c, adjacente, mais en aval de la zone aval 2a précitée du premier moyen 2 de diffusion, cette zone adjacente étant également accessible à une observation externe, par exemple avec la même fenêtre 1d du boítier 1 ;
    • un organe de captation 4 de l'échantillon liquide, monté sur le support 1 de manière amovible, ou inversement ; cet organe 4 comporte un deuxième moyen 41 de diffusion capillaire, dans la même direction et le même sens 60 que ceux déterminés par le premier moyen 2 de diffusion capillaire ; ce deuxième moyen 41 s'étend de la zone de collection 41a de l'échantillon, à une zone de transfert 41b de ce dernier ; cet organe de captation 4 est mobile et déplaçable en translation, par rapport au support de préhension 1, entre deux positions extrêmes, à savoir l'une saillante (cf. figure 1) par rapport audit support de préhension, dans laquelle la zone de collection 41a est susceptible d'être mise en contact avec l'échantillon liquide, en dehors du support de préhension, et dans laquelle la zone de transfert (41b) n'est pas en continuité d'écoulement capillaire avec, et donc isolée par rapport à la zone amont (2b) du premier moyen (2) de diffusion capillaire, et l'autre rétractée (cf. figure 2), dans laquelle la zone de collection 41a est comprise dans ledit support de préhension, et dans laquelle la zone de transfert (41b) du deuxième moyen (41) de diffusion capillaire est, de manière amovible, c'est à dire temporaire, en continuité d'écoulement capillaire avec la zone amont (2b) du premier moyen (2) de diffusion capillaire ; ce qui explique que l'organe de captation 4 et le support de préhension 1 sont allongés selon la direction de translation.
    According to FIGS. 1 and 2, a device according to the invention comprises:
    • a gripping support 1 having the shape of a housing, comprising, at a distal end, an opening 1c for the passage of the capturing member 4 described hereinafter towards the projecting position, and opposite this end a window 1d registered with at least one downstream zone 2a of the first capillary diffusion means 2, described hereinafter;
    • the first of the two capillary diffusion means, in the form of a multi-layer strip, secured to the gripping support 1, and comprising the downstream zone 2a accessible to an external observation; this first means is more particularly shown in exploded view in FIG. 2, and will be described hereinafter in detail;
    • a set of predetermined reagents for the detection and / or quantification of the analyte, comprising at least:
      • a first reagent 31, comprising a visible and / or measurable marker, this first reagent being placed in the free state on the first diffusion means 2, in particular downstream of the upstream zone 2b, which will be discussed below;
      • and a second reagent 32 fixed in the downstream zone 2a of the first diffusion means 2, for the direct or indirect capture of the first reagent;
      • another reagent 33, predetermined to bind with the first reagent 31, fixed in an area 2c, adjacent but downstream of the aforementioned downstream zone 2a of the first diffusion means 2, this adjacent zone being also accessible to an external observation, for example with the same window 1d of the housing 1;
    • a capture member 4 of the liquid sample, mounted on the support 1 removably, or vice versa; this member 4 comprises a second means 41 of capillary diffusion, in the same direction and the same direction 60 as those determined by the first means 2 of capillary diffusion; this second means 41 extends from the collection zone 41a of the sample, to a transfer zone 41b of the latter; this capturing member 4 is movable and displaceable in translation, with respect to the gripping support 1, between two extreme positions, namely one protruding (see FIG. 1) with respect to said gripping support, in which the collection zone 41a is capable of being brought into contact with the liquid sample, outside the gripping support, and in which the transfer zone (41b) is not in continuity of capillary flow with, and therefore isolated from the upstream zone (2b) of the first capillary diffusion means (2) and the other retracted region (see FIG. 2), in which the collection zone 41a is included in the said gripping support, and in which the transfer zone (41b) of the second capillary diffusion means (41) is removably, ie temporarily, in continuity of capillary flow with the upstream zone (2b) of the first capillary diffusion means (2); this explains that the capturing member 4 and the gripping support 1 are elongate in the direction of translation.

    En correspondance avec la structure générale décrite précédemment :

    • la zone amont 2b du premier moyen 2 de diffusion capillaire est agencée pour venir, de manière amovible ou temporaire, en continuité d'écoulement capillaire avec la zone de transfert 41b du second moyen 41 de diffusion capillaire, dans la position rétractée de l'organe de captation 4, et pour être isolée vis à vis du même écoulement capillaire, par rapport à la même zone de transfert 41b, dans la position saillante de l'organe de captation 4.
    • et le premier réactif 31 est déposé à l'état libre sur le premier moyen de diffusion 2, comme décrit précédemment, dans une zone 2a en aval de la zone amont 2b ; mais bien entendu, le premier réactif peut être déposé directement dans la zone amont 2b du premier moyen 2 de diffusion capillaire, ou encore directement sur le deuxième moyen 41 de diffusion capillaire.
    In correspondence with the general structure described above:
    • the upstream zone 2b of the first capillary diffusion means 2 is arranged to come, removably or temporarily, in capillary flow continuity with the transfer zone 41b of the second capillary diffusion means 41, in the retracted position of the organ 4, and to be isolated with respect to the same capillary flow, with respect to the same transfer zone 41b, in the protruding position of the capture member 4.
    • and the first reagent 31 is deposited in the free state on the first diffusion means 2, as previously described, in an area 2a downstream of the upstream zone 2b; but of course, the first reagent can be deposited directly in the upstream zone 2b of the first capillary diffusion means 2, or directly on the second capillary diffusion means 41.

    Pour actionner le déplacement de l'organe de captation 4, comme montré à la figure 2, le support de préhension 1 comporte une glissière longitudinale 5, dont la forme est adaptée à la trajectoire de déplacement dudit organe 4, et ce dernier comporte un organe 6 de commande manuelle traversant cette glissière. La course de l'organe 6 dans la glissière 5 détermine le deux positions extrêmes de l'organe de captation 4, et comme montré à la figure 2, a une longueur supérieure à la longueur de recouvrement de la zone de transfert 41b du deuxième moyen 41 de diffusion capillaire, et de la zone amont (2b) du premier moyen de diffusion capillaire, dans la position rétractée du dispositif.To actuate the displacement of the organ capture 4, as shown in Figure 2, the support of 1 comprises a longitudinal slide 5, of which the shape is adapted to the movement path of said member 4, and the latter comprises a control member 6 manual crossing this slide. The race of the organ 6 in the slide 5 determines the two extreme positions of the capture member 4, and as shown in FIG. has a length greater than the recovery length of the transfer zone 41b of the second diffusion means 41 capillary, and the upstream zone (2b) of the first means of capillary diffusion, in the retracted position of device.

    Comme montré plus particulièrement par la figure 7, le premier moyen 2 de diffusion capillaire est obtenu par assemblage de différentes sections ou morceaux, eux-mêmes fixés sur une bande 28 en matière plastique transparente, et en continuité permanente d'écoulement capillaire une fois assemblés les uns aux autres. As shown more particularly by the FIG. 7, the first means 2 of capillary diffusion is obtained by assembling different sections or pieces, themselves fixed on a band 28 made of plastic transparent, and in permanent continuity of flow capillary when assembled to each other.

    Conformément à la figure 7, et dans le sens et la direction 60 de l'écoulement capillaire, en plus de la bande 28 transparente, le premier moyen de diffusion capillaire 2 comporte :

    • une première section 21 de porosité relativement importante, par exemple en cellulose, avec une taille de pores comprise entre 2 µm et 50 µm, agencée pour venir en continuité d'écoulement capillaire avec la zone de transfert 41b du second moyen 41 de diffusion capillaire ; c'est cette section qui constitue la zone amont 2b du premier moyen 2 de diffusion ;
    • une section 22 constituée par exemple en fibre de verre, ayant une taille de pores comprise entre 2 µm et 500 µm, sur laquelle est déposé à l'état libre le premier réactif 31 ;
    • une section 24 de porosité relativement faible, par exemple constituée en nitrocellulose, avec une porosité comprise entre 1 µm et 30 µm, comportant, et la zone aval 2a dans laquelle est fixé le second réactif 32, et la zone adjacente dans laquelle est fixé l'autre réactif 33, ces deux zones étant accessibles à une observation externe par la fenêtre registrée 1d du boítier 1 ;
    • une section 27, constituée par exemple en cellulose, ayant une porosité comprise entre 2 µm et 50 µm, pour le recueil par absorption de l'ensemble des liquides ayant circulé sur le premier moyen 2 de diffusion capillaire, au-delà des zones aval 2a ; cette section de recueil est donc solidaire du support préhension 1, et disposée en aval et en continuité d'écoulement capillaire avec la zone aval 2a du premier moyen de diffusion capillaire 1.
    According to FIG. 7, and in the direction and direction 60 of the capillary flow, in addition to the transparent band 28, the first capillary diffusion means 2 comprises:
    • a first section 21 of relatively large porosity, for example cellulose, with a pore size of between 2 microns and 50 microns, arranged to come into capillary flow continuity with the transfer zone 41b of the second capillary diffusion means 41; it is this section which constitutes the upstream zone 2b of the first diffusion means 2;
    • a section 22 constituted for example by fiberglass, having a pore size of between 2 μm and 500 μm, on which the first reagent 31 is deposited in the free state;
    • a section 24 of relatively low porosity, for example consisting of nitrocellulose, with a porosity of between 1 .mu.m and 30 .mu.m, comprising, and the downstream zone 2a in which the second reagent 32 is fixed, and the adjacent zone in which is fixed other reagent 33, these two zones being accessible to external observation by the registered window 1d of the housing 1;
    • a section 27, constituted for example by cellulose, having a porosity of between 2 μm and 50 μm, for the collection by absorption of all the liquids having circulated on the first capillary diffusion means 2, beyond the downstream zones 2a ; this collection section is thus secured to the gripping support 1, and disposed downstream and in continuity of capillary flow with the downstream zone 2a of the first capillary diffusion means 1.

    Le dispositif conforme aux figures 3 à 5 a la même structure générale que celle définie précédemment. Les mêmes références numériques identifient des pièces ou composants ayant la même fonction que celle décrite par référence aux figures 1 et 2. Seules les différences suivantes seront décrites ci-après.The device according to Figures 3 to 5 has the same general structure as defined above. The same numerical references identify parts or components having the same function as that described by reference to Figures 1 and 2. Only the differences following will be described below.

    L'organe de captation 4 comprend un chariot 42 de support du second moyen 41 de diffusion capillaire, compris dans le boítier 1 ou support de préhension. Ce dernier et le chariot 42 comportent des moyens de guidage en déplacement dudit chariot, plus particulièrement visibles sur la figure 6, consistant en deux glissières 45 et 46 appartenant au boítier 1, l'une supérieure et l'autre inférieure, et alignées, et en deux nervures correspondantes 43 et 44 appartenant au chariot 42, coulissant dans les glissières 45 et 46 respectivement.The capture member 4 comprises a carriage 42 of supporting the second means 41 of capillary diffusion, included in the housing 1 or gripping support. This last and the carriage 42 comprise guide means moving said carriage, more particularly visible in Figure 6, consisting of two slides 45 and 46 belonging to the housing 1, the superior and the other bottom, and aligned, and in two ribs 43 and 44 corresponding to the carriage 42, sliding in the slides 45 and 46 respectively.

    Le second moyen de diffusion 41 a la forme d'un bâtonnet relativement rigide, et le chariot 42 comporte une butée arrière 42a par rapport au sens de déplacement dudit chariot, et un organe 42b de maintien en position du bâtonnet 41, ayant la forme d'un anneau.The second diffusion means 41 is in the form of a relatively rigid rod, and the carriage 42 comprises a rear stop 42a with respect to the direction of travel said carriage, and a member 42b for holding the rod 41, having the shape of a ring.

    Le boítier 1 intègre également un moyen 47 d'actionnement du chariot 42, avec une commande manuelle 48. Plus précisément, le moyen d'actionnement 47 comprend une bande 49 semi-rigide, conformée en épingle, dont une branche 49a comporte sur sa face extérieure un organe 48 de préhension, et dont l'autre branche a une extrémité liée au chariot 42. En correspondance, le boítier 1 comprend un chemin 50 de guidage et tirage de la bande, également conformé en épingle, et d'autre part une fenêtre 1f adaptée au passage de l'organe de préhension 48, dont la longueur est adaptée à la course de déplacement de l'organe de captation 4. comme le montre bien le rapprochement des figures 4 et 5, cette course a une longueur bien supérieure à la longueur de recouvrement de la zone de transfert 41 b du deuxième moyen de diffusion capillaire 41, et de la zone amont 2b du premier moyen de diffusion capillaire 2, dans la position rétractée du dispositif. The housing 1 also includes a means 47 for actuating the carriage 42, with manual control 48. More specifically, the actuating means 47 comprises a band 49 semi-rigid, shaped hairpin, one of which branch 49a has on its outer face a member 48 the other limb has one end linked to the carriage 42. In correspondence, the housing 1 comprises a path 50 for guiding and pulling the strip, also shaped hairpin, and secondly a 1f window adapted to the passage of the organ of 48, the length of which is adapted to the race of displacement of the capture organ 4. as shown the comparison between figures 4 and 5, this race a much longer length than the recovery length of the transfer zone 41b of the second means of capillary diffusion 41, and the upstream zone 2b of the first capillary diffusion means 2, in the position retracted device.

    Par conséquent, en repoussant l'organe 48 de préhension vers l'extrémité proximale du boítier 1, comme montré à la figure 3, la bande 49 circule dans le chemin 50 de guidage et repousse le chariot 42 vers la position saillante de l'organe de captation 2. En sens inverse, le chariot 42 est déplacé vers la position rétractée de l'organe de captation 4.Therefore, by pushing organ 48 gripping towards the proximal end of the housing 1, as shown in FIG. 3, the band 49 circulates in the guide path 50 and pushes the carriage 42 towards the protruding position of the capture member 2. In sense reverse, the carriage 42 is moved to the position retracted from the capture member 4.

    Comme le montrent également les figures 4 et 5, le premier moyen 2 de diffusion capillaire est serré et maintenu à l'intérieur du boítier entre des nervures le disposées parallèlement à la direction 60 du flux capillaire.As also shown in Figures 4 and 5, the first means 2 of capillary diffusion is tight and kept inside the housing between ribs on arranged parallel to the flow direction 60 capillary.

    Le fonctionnement d'un dispositif selon l'invention se déduit de la description précédente :

    • au départ, c'est-à-dire avant utilisation, l'organe 4 de captation est dans la position rétractée (cf. Fig.2 et 4), de telle sorte que le boítier 1 est une entité fermée, à l'exception de la fenêtre 1d ; dans le cas de la figure 1, c'est un volet 61, solidaire de l'extrémité proximale de l'organe de captation 4, qui ferme l'ouverture 1c ; et dans le cas des figures 4 et 5, c'est l'extrémité de la bande 49 semi-rigide, opposée au chariot 42, qui obture l'ouverture 1c (cf. figure 5) ;
    • par l'organe de commande 6 ou 48, l'utilisateur amène l'organe de captation 4 dans la position saillante, dans laquelle un flux ou échantillon liquide contenant l'analyte est mis en contact avec la zone de collection 41a ;
    • avec la même main, le même organe de captation est ramené dans la position rétractée, avec fermeture de l'ouverture 1c, comme décrit précédemment
    • c'est uniquement dans cette dernière position, sans autre intervention de l'utilisateur, que l'échantillon liquide migre successivement du deuxième moyen de diffusion capillaire 41, vers le premier moyen de diffusion capillaire 42, et sur ce dernier de l'amont vers l'aval ; les réactions générées par les réactifs précédemment décrits s'effectuent ; le résultat est accessible à une observation externe par la fenêtre 1d, par exemple à l'oeil nu ;
    • puis le dispositif de détermination, à usage unique, peut être jeté, dans la position rétractée des Figures 2 et 4.
    The operation of a device according to the invention is deduced from the preceding description:
    • initially, that is to say before use, the capture member 4 is in the retracted position (see Fig.2 and 4), so that the housing 1 is a closed entity, with the exception from window 1d; in the case of Figure 1, it is a flap 61 integral with the proximal end of the sensor member 4, which closes the opening 1c; and in the case of Figures 4 and 5, it is the end of the band 49 semi-rigid, opposite the carriage 42, which closes the opening 1c (see Figure 5);
    • by the control member 6 or 48, the user brings the sensor member 4 into the projecting position, in which a flow or liquid sample containing the analyte is brought into contact with the collection zone 41a;
    • with the same hand, the same capture member is returned to the retracted position, with closure of the opening 1c, as previously described
    • it is only in this latter position, without further intervention by the user, that the liquid sample migrates successively from the second capillary diffusion means 41, to the first capillary diffusion means 42, and on the latter from the upstream to the the downstream; the reactions generated by the reagents described above are carried out; the result is accessible to an external observation through the window 1d, for example with the naked eye;
    • then the disposable determination device can be discarded in the retracted position of Figures 2 and 4.

    Conformément à la figure 5, par rapport au sens de l'observation par la fenêtre 1d, on observera que la zone de transfert 41b du deuxième moyen 41 de diffusion capillaire vient au-dessous de la zone amont 2b du premier moyen 2 de diffusion capillaire, dans la position rétractée de l'organe 4 de captation, et ce pour favoriser l'écoulement capillaire à la jonction entre les deux moyens 2 et 41 de diffusion capillaire, dans la position rétractée de l'organe de captation 4.In accordance with Figure 5, in relation to the meaning of the observation by the window 1d, it will be observed that the zone 41b transfer of the second means 41 broadcast capillary comes below the upstream zone 2b of the first medium 2 capillary diffusion, in the position retracted organ 4 capture, and this to promote the capillary flow at the junction between the two means 2 and 41 of capillary diffusion, in the position retracted from the capture member 4.

    Claims (11)

    1. Device for determination of an analyte in a liquid sample, comprising:
      a) a support (1) to be gripped;
      b) a first means (2) for capillary diffusion in a reference direction (60), secured to the support (1) to the gripped, comprising a downstream zone (2a) which is accessible to external observation;
      c) a predetermined reagent (32) for detecting and/or quantifying the analyte, fixed in the downstream zone (2a) of the first capillary diffusion means;
      d) a second capillary diffusion means (41) with, on the one hand, a zone (41a) for collecting the said sample and, on the other hand, a transfer zone (41b) opposite the said collection zone (41a);
      e) a component (4) for taking up the liquid sample, to which the second capillary diffusion means (41) is secured, mounted so that it can move with respect to the said support to be gripped, between two extreme positions, namely:
      one which protrudes from the said support to be gripped, in which the collecting zone (41a) of the second capillary diffusion means (41) can be brought into contact with the liquid sample outside of the support to be gripped,
      and the other which is retracted, in which the collection zone (41a) of the second capillary diffusion means (41) is contained in the support to be gripped,
      characterized in that the transfer zone (41b) of the second capillary diffusion means (41) is arranged removably, with respect to an upstream zone (2b) of the first capillary diffusion means (2), so that when the take-up member (4) is in the protruding position), the said transfer zone (41b) is not in capillary flow continuity with the said upstream zone (2b), and when the said take-up member (4) is in the retracted position, the said transfer zone (41b) and the said upstream zone (2b) are in capillary flow continuity, whereas a predetermined set of reagents for detecting and/or quantifying the analyte comprises, at least, on the one hand, a reagent (31) comprising a visible and/or measurable marker, deposited in the free state either on the first capillary diffusion means (2), upstream of the downstream zone (2a), or on the second capillary diffusion means (41) and, on the other hand, the reagent fixed in the downstream zone (2a) of the first capillary diffusion means for the direct or indirect take-up of the reagent comprising the marker.
    2. Device according to Claim 1, characterized in that the reagent (31) comprising the marker is deposited on the second diffusion means (41), in particular downstream of the collection zone (41a).
    3. Device according to Claim 1, characterized in that the reagent (31) comprising the marker is deposited on the first diffusion means (2), in particular downstream of the said upstream zone (2b).
    4. Device according to Claim 1, characterized in that the support (1) to be gripped is in the form of a kit which, at one end, comprises an opening (1c) for the take-up component (4) to pass through into the protruding position, and on the opposite side from the said end, a window (1d) registered with at least the downstream zone (2a) of the first capillary diffusion means (2).
    5. Device according to Claim 1, characterized in that the support (1) to be gripped includes a slideway (5) whose shape is adapted to the path along which the take-up component (4) moves, and the said take-up component includes a manual control component (6) passing through the said slideway.
    6. Device according to Claim 1, characterized in that the take-up component (4) can be moved and be translated relative to the support (1) to be gripped, and the said component and the said support are elongated in the translation direction.
    7. Device according to Claim 1, characterized in that the first capillary diffusion means (2) includes two separate sections, in permanent capillary flow continuity, namely a first section (21) of relatively high porosity, designed to come removably into capillary flow continuity with the transfer zone (41b) of the second capillary diffusion means (41), and a second section (24) of relatively low porosity, including the said downstream zone (2a).
    8. Device according to Claim 4, characterized in that the take-up component (4) comprises a carriage (42) for supporting the second capillary diffusion means (41), the kit and the carriage includes means (43 to 46) for guiding the said carriage as it moves, and the kit incorporates a means (47) for actuating the said carriage, with manual control (48).
    9. Device according to Claim 8, characterized in that the second diffusion means (41) is in the form of a stick, and the carriage includes a rear stop (42a) relative to the direction of movement, and a component (42b) for holding the said stick in position.
    10. Device according to Claim 8, characterized in that the actuation means (47) comprises a hairpin-shaped semirigid band (49), one branch (49a) of which has a component (48) to be gripped on its outer face, and the other branch (49b) of which has an end joined to the carriage (42), and in that the kit (1) comprises, on the one hand, a path (50) which is intended for pulling the band and is also shaped as a hairpin, and on the other hand a window (1d) which is designed for the passage of the component (48) to be gripped, and whose length is adapted to the displacement travel of the take-up component (4).
    11. Device according to Claim 4, characterized in that the first capillary diffusion means (2) is clamped and held inside the kit, between ribs (1c) extending parallel to the direction of the capillary flow.
    EP99925064A 1998-06-30 1999-06-10 Device for determining an analyte in a liquid sample Expired - Lifetime EP1091808B1 (en)

    Applications Claiming Priority (3)

    Application Number Priority Date Filing Date Title
    FR9808480 1998-06-30
    FR9808480A FR2780317B1 (en) 1998-06-30 1998-06-30 DEVICE FOR DETERMINING AN ANALYTE IN A LIQUID SAMPLE
    PCT/FR1999/001380 WO2000000288A1 (en) 1998-06-30 1999-06-10 Device for determining an analyte in a liquid sample

    Publications (2)

    Publication Number Publication Date
    EP1091808A1 EP1091808A1 (en) 2001-04-18
    EP1091808B1 true EP1091808B1 (en) 2003-07-09

    Family

    ID=9528186

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP99925064A Expired - Lifetime EP1091808B1 (en) 1998-06-30 1999-06-10 Device for determining an analyte in a liquid sample

    Country Status (16)

    Country Link
    US (1) US7459125B1 (en)
    EP (1) EP1091808B1 (en)
    JP (1) JP4505138B2 (en)
    CN (1) CN1185050C (en)
    AT (1) ATE244602T1 (en)
    AU (1) AU4148399A (en)
    CA (1) CA2335458A1 (en)
    DE (1) DE69909484T2 (en)
    ES (1) ES2204132T3 (en)
    FR (1) FR2780317B1 (en)
    HU (1) HUP0102735A3 (en)
    IL (1) IL140165A (en)
    PL (1) PL194051B1 (en)
    RS (1) RS49670B (en)
    RU (1) RU2205693C2 (en)
    WO (1) WO2000000288A1 (en)

    Cited By (2)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    FR2873208A1 (en) * 2004-07-13 2006-01-20 Vedalab Sa DEVICE WITH A SAMPLING MEMBER FOR DETECTION OF AN ANALYTE IN A LIQUID SAMPLE
    US8709826B2 (en) 2005-08-23 2014-04-29 Vedalab Analyte assaying by means of immunochromatography with lateral migration

    Families Citing this family (18)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US6773677B2 (en) * 2002-01-09 2004-08-10 Caliper Life Sciences, Inc. Slide cassette for fluidic injection
    ES2525318T3 (en) * 2002-10-11 2014-12-22 Zbx Corporation Diagnostic devices
    EP1718973B1 (en) * 2004-02-09 2009-09-09 Rapid Pathogen Screening Inc. Method for the rapid diagnosis of targets in human body fluids
    CN101498717B (en) * 2005-04-30 2013-08-28 美艾利尔瑞士公司 Sample collecting device used for collecting solid or semi-solid sample
    GB0811132D0 (en) * 2008-06-18 2008-07-23 Secr Defence Detection device
    WO2010009301A1 (en) * 2008-07-17 2010-01-21 The Procter & Gamble Company Method of using a flow cell apparatus for visualizing additive deposition on a substrate
    AU2010330825B2 (en) * 2009-12-18 2014-03-06 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge
    BG110608A (en) * 2010-03-01 2011-09-30 Zentax Limited Pregnancy tester
    US9744014B2 (en) * 2010-10-15 2017-08-29 Nestec S.A. Oral engagement assemblies
    FR2997194B1 (en) 2012-10-24 2014-11-28 Milovan Stankov DEVICE FOR DETERMINING AT LEAST ONE ANALYTE LIKELY TO BE CONTAINED IN A LIQUID SAMPLE
    US9592507B2 (en) * 2012-06-22 2017-03-14 Abbott Point Of Care Inc. Integrated cartridge housings for sample analysis
    MX2017013898A (en) * 2015-04-30 2018-08-15 Wellmetris Llc Sample collection device and method for urine and other fluids.
    WO2018079916A1 (en) * 2016-10-28 2018-05-03 주식회사 바이탈스미스 Image processing and analyzing system for ovulation detection and method for controlling same
    CN109890297A (en) * 2016-10-28 2019-06-14 株式会社马尼金 For determining the image processing and analysis system and its control method of ovulation day
    EP3619532B1 (en) 2017-05-02 2022-07-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Plasma/serum separator device and methods using the same
    GB201816559D0 (en) * 2018-10-10 2018-11-28 Spd Swiss Prec Diagnostics Gmbh Compact testing device
    EP4188600B1 (en) 2020-07-29 2024-06-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Device for separation and/or preservation of a biofluid at a point-of-care, kit and method for identifying a disease
    CA3167468A1 (en) * 2022-03-15 2023-09-15 Zhejiang Orient Gene Biotech Co., Ltd. Device for detecting an analyte in a liquid sample

    Family Cites Families (14)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US4774192A (en) * 1987-01-28 1988-09-27 Technimed Corporation A dry reagent delivery system with membrane having porosity gradient
    DE291194T1 (en) 1987-04-27 1992-03-19 Unilever N.V., Rotterdam IMMUNOASSAYS AND DEVICES FOR THIS.
    US4981786A (en) * 1987-09-04 1991-01-01 Syntex (U.S.A.) Inc. Multiple port assay device
    ATE154979T1 (en) * 1993-03-17 1997-07-15 Akzo Nobel Nv DEVICE FOR DETERMINING A SPECIFIC REACTING SUBSTANCE
    JP2665647B2 (en) * 1993-07-08 1997-10-22 三共株式会社 Portable diagnostic tool
    WO1995008761A1 (en) * 1993-09-20 1995-03-30 Polyfiltronics, Inc. Analytical test formats and methods of conducting analytical tests
    IT1281738B1 (en) * 1996-01-17 1998-02-27 Boehringer Mannheim Italia DEVICE FOR PERFORMING RAPID DIAGNOSTIC TESTS ON LIQUID SAMPLES
    US5980828A (en) * 1996-05-28 1999-11-09 Universal Healthwatch, Inc. Combined sampling-assay device and holder
    AUPO071396A0 (en) * 1996-06-28 1996-07-25 Chandler, Howard Milne Chromatographic assay or test device
    JP3753282B2 (en) * 1996-07-29 2006-03-08 久光製薬株式会社 Inspection device
    US6372514B1 (en) * 1998-09-18 2002-04-16 Syntron Bioresearch, Inc. Even fluid front for liquid sample on test strip device
    US6140136A (en) * 1998-09-18 2000-10-31 Syntron Bioresearch, Inc. Analytical test device and method of use
    US6150178A (en) * 1999-03-24 2000-11-21 Avitar, Inc. Diagnostic testing device
    US6365417B1 (en) * 2000-02-09 2002-04-02 A-Fem Medical Corporation Collection device for lateral flow chromatography

    Cited By (4)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    FR2873208A1 (en) * 2004-07-13 2006-01-20 Vedalab Sa DEVICE WITH A SAMPLING MEMBER FOR DETECTION OF AN ANALYTE IN A LIQUID SAMPLE
    WO2006016051A2 (en) * 2004-07-13 2006-02-16 Vedalab Device with removal member for detecting an analyte in a liquid sample
    WO2006016051A3 (en) * 2004-07-13 2006-08-10 Vedalab Device with removal member for detecting an analyte in a liquid sample
    US8709826B2 (en) 2005-08-23 2014-04-29 Vedalab Analyte assaying by means of immunochromatography with lateral migration

    Also Published As

    Publication number Publication date
    IL140165A0 (en) 2002-02-10
    IL140165A (en) 2004-05-12
    RU2205693C2 (en) 2003-06-10
    ES2204132T3 (en) 2004-04-16
    CN1185050C (en) 2005-01-19
    FR2780317A1 (en) 1999-12-31
    HUP0102735A2 (en) 2001-11-28
    YU83300A (en) 2003-04-30
    RS49670B (en) 2007-09-21
    DE69909484D1 (en) 2003-08-14
    DE69909484T2 (en) 2004-04-15
    US7459125B1 (en) 2008-12-02
    JP2002519650A (en) 2002-07-02
    EP1091808A1 (en) 2001-04-18
    WO2000000288A1 (en) 2000-01-06
    ATE244602T1 (en) 2003-07-15
    AU4148399A (en) 2000-01-17
    JP4505138B2 (en) 2010-07-21
    PL194051B1 (en) 2007-04-30
    CA2335458A1 (en) 2000-01-06
    CN1308562A (en) 2001-08-15
    FR2780317B1 (en) 2000-08-11
    HUP0102735A3 (en) 2005-11-28
    PL345160A1 (en) 2001-12-03

    Similar Documents

    Publication Publication Date Title
    EP1091808B1 (en) Device for determining an analyte in a liquid sample
    JP4314232B2 (en) Biochemical assay
    JP4891317B2 (en) Membrane array and analytical equipment
    US6372516B1 (en) Lateral flow test device
    US20040019301A1 (en) Integrated confirmation sample in a body fluid test device and method of using
    EP1917529B1 (en) Analyte assaying by means of immunochromatography with lateral migration
    US6770447B2 (en) Optical assay device and method
    JP3727952B2 (en) Automated immunoassay cassette
    US20100068826A1 (en) Hybrid phase lateral flow assay
    JP2004509319A (en) Assay device and method of using the same
    WO2006016051A2 (en) Device with removal member for detecting an analyte in a liquid sample
    WO1998048280A1 (en) Device for detection of a substance in a liquid sample
    JP3791640B2 (en) Inspection device
    US20080311680A1 (en) Method for detecting high antigen concentration and device therefor
    WO2022029083A1 (en) System for rapid analysis of a biological sample, intended for detecting the presence of at least one analyte in the biological sample
    EP1870160A1 (en) Package for body secretion collecting tool
    EP4281772A1 (en) System for rapid analysis of a capillary blood sample from a subject, for detecting the presence of at least one analyte in said capillary blood sample
    WO2023222728A1 (en) System for rapid analysis of a biological sample intended for detecting the presence of at least one analyte in the biological sample
    MXPA00012516A (en) Device for determining an analyte in a liquid sample
    ITMI971406A1 (en) IMMUNOCROMATOGRAPHIC DEVICE FOR FIXING THE ANALYT
    WO2022207890A1 (en) Device for rapid analysis of a biological sample, for example a salivary biological sample
    FR2875910A1 (en) Immuno-chromatographic diagnostic test strip for detection of specific analyte in liquid, includes second bonding reagent combined with marker which is visible or can be measured
    FR2883375A1 (en) Body secretion e.g. saliva, analyzing package for detecting consumption of e.g. marihuana, has swab including padded end introduced in input end of channel and sliding along length of channel to make contact with strip of cassette
    FR3111430A1 (en) System for the rapid analysis of a biological sample, intended for the detection of the presence of at least one analyte in said biological sample
    WO2023067288A1 (en) System for detecting a target substance in a sample

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    17P Request for examination filed

    Effective date: 20010129

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

    AX Request for extension of the european patent

    Free format text: AL PAYMENT 20010129;LT PAYMENT 20010129;LV PAYMENT 20010129;MK PAYMENT 20010129;RO PAYMENT 20010129;SI PAYMENT 20010129

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    17Q First examination report despatched

    Effective date: 20020612

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

    AX Request for extension of the european patent

    Extension state: AL LT LV MK RO SI

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: CY

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20030709

    Ref country code: AT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20030709

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: FG4D

    Free format text: NOT ENGLISH

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: EP

    REF Corresponds to:

    Ref document number: 69909484

    Country of ref document: DE

    Date of ref document: 20030814

    Kind code of ref document: P

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: FG4D

    Free format text: FRENCH

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GR

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20031009

    Ref country code: DK

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20031009

    REG Reference to a national code

    Ref country code: SE

    Ref legal event code: TRGR

    GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

    Effective date: 20031104

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: PT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20031209

    LTIE Lt: invalidation of european patent or patent extension

    Effective date: 20030709

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FG2A

    Ref document number: 2204132

    Country of ref document: ES

    Kind code of ref document: T3

    PLBE No opposition filed within time limit

    Free format text: ORIGINAL CODE: 0009261

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: LU

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20040610

    26N No opposition filed

    Effective date: 20040414

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: MC

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20040630

    Ref country code: LI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20040630

    Ref country code: CH

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20040630

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20040630

    BERE Be: lapsed

    Owner name: *VEDALAB

    Effective date: 20040630

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: PL

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FI

    Payment date: 20060519

    Year of fee payment: 8

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: IE

    Payment date: 20060523

    Year of fee payment: 8

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: IT

    Payment date: 20070616

    Year of fee payment: 9

    REG Reference to a national code

    Ref country code: HK

    Ref legal event code: WD

    Ref document number: 1038523

    Country of ref document: HK

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: FI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070610

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: MM4A

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070611

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: NL

    Payment date: 20090527

    Year of fee payment: 11

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IT

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20080610

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: SE

    Payment date: 20090518

    Year of fee payment: 11

    REG Reference to a national code

    Ref country code: NL

    Ref legal event code: V1

    Effective date: 20110101

    EUG Se: european patent has lapsed
    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: NL

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20110101

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20100611

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 18

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 19

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 20

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: DE

    Payment date: 20180416

    Year of fee payment: 20

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FR

    Payment date: 20180412

    Year of fee payment: 20

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: GB

    Payment date: 20180412

    Year of fee payment: 20

    Ref country code: ES

    Payment date: 20180725

    Year of fee payment: 20

    REG Reference to a national code

    Ref country code: DE

    Ref legal event code: R071

    Ref document number: 69909484

    Country of ref document: DE

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: PE20

    Expiry date: 20190609

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

    Effective date: 20190609

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FD2A

    Effective date: 20200724

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: ES

    Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

    Effective date: 20190611